Associate Ellaway - Neurotech International Chief Officer
| NTI Stock | 0.04 0 2.70% |
Executive
Associate Ellaway is Chief Officer of Neurotech International
| Phone | 61 8 9389 3130 |
| Web | https://www.neurotechinternational.com |
Neurotech International Management Efficiency
The company has return on total asset (ROA) of (1.2979) % which means that it has lost $1.2979 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.238) %, meaning that it generated substantial loss on money invested by shareholders. Neurotech International's management efficiency ratios could be used to measure how well Neurotech International manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Timothy Laneyrie | Andean Silver Limited | N/A | |
| Andrew Leyden | Collins Foods | N/A | |
| Tony Ark | Collins Foods | N/A | |
| Adam Thatcher | Collins Foods | N/A | |
| David Kelley | Collins Foods | N/A | |
| David Timm | Collins Foods | N/A | |
| Hans Miete | Collins Foods | N/A | |
| Joanne Matthews | Collins Foods | N/A | |
| Caroline Gatenby | Autosports Group | N/A | |
| Andrew Bickley | Andean Silver Limited | N/A | |
| F BBus | Andean Silver Limited | N/A | |
| LLB BCom | Collins Foods | N/A | |
| ACA BBus | Andean Silver Limited | 63 | |
| BEc BA | Collins Foods | 62 | |
| BA LLB | Collins Foods | N/A | |
| Chris Tan | Sports Entertainment Group | N/A | |
| Damien Koerber | Andean Silver Limited | N/A | |
| Helen Moore | Collins Foods | N/A | |
| Nigel Williams | Collins Foods | N/A | |
| Maddison Cramer | Andean Silver Limited | N/A | |
| Priyamvada Rasal | Collins Foods | N/A | |
Management Performance
| Return On Equity | -2.24 | ||||
| Return On Asset | -1.3 |
Neurotech International Leadership Team
Elected by the shareholders, the Neurotech International's board of directors comprises two types of representatives: Neurotech International inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Neurotech. The board's role is to monitor Neurotech International's management team and ensure that shareholders' interests are well served. Neurotech International's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Neurotech International's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Emanuela Russo, Chief Board | ||
| Alessandra Gauvin, Company Secretary | ||
| Anthony Filippis, CEO MD | ||
| Alexandra Andrews, Chief Officer | ||
| Peter BSc, Chief Ltd | ||
| AO AO, Chief Director | ||
| Associate Ellaway, Chief Officer | ||
| ACIS ACIS, Company Sec | ||
| Thomas MBA, Executive Director | ||
| Anthony MBA, CEO MD | ||
| Gerald Quigley, Director Director |
Neurotech Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Neurotech International a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.24 | ||||
| Return On Asset | -1.3 | ||||
| Operating Margin | (65.47) % | ||||
| Current Valuation | 32.59 M | ||||
| Shares Outstanding | 1.04 B | ||||
| Shares Owned By Insiders | 32.54 % | ||||
| Shares Owned By Institutions | 2.22 % | ||||
| Price To Book | 6.72 X | ||||
| Price To Sales | 479.13 X | ||||
| Revenue | 1.96 K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Neurotech Stock Analysis
When running Neurotech International's price analysis, check to measure Neurotech International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurotech International is operating at the current time. Most of Neurotech International's value examination focuses on studying past and present price action to predict the probability of Neurotech International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurotech International's price. Additionally, you may evaluate how the addition of Neurotech International to your portfolios can decrease your overall portfolio volatility.